Skip to main content
AdaptHealth Corp. logo

AdaptHealth Corp. — Investor Relations & Filings

Ticker · AHCO ISIN · US00653Q1022 US Human health and social work activities
Open in API
Filings indexed 694 across all filing types
Latest filing 2020-08-03 Board/Management Inform…
Country US United States of America
Listing US AHCO

About AdaptHealth Corp.

https://adapthealth.com/investor-relati…

AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions. The company specializes in home medical equipment (HME), medical supplies, and related services. Its core offerings support various patient needs, including sleep health, respiratory therapy, and general wellness at home. Key product categories include sleep therapy equipment like CPAP and BiPAP devices, home oxygen therapy supplies, and a wide range of other durable medical equipment. Operating as a network of full-service medical equipment companies, AdaptHealth provides tailored products and services to enable patients to manage their health from home.

Recent filings

Filing Released Lang Actions
424B3
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed by AdaptHealth Corp. It includes an announcement of the appointment of a new board member, David S. Williams III, to the company's Board of Directors. The text details the background of the new director, the board expansion, and related indemnification agreements. There is no financial data or comprehensive report content; rather, it is a regulatory filing announcing a management/board change. Therefore, the document fits the category of Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a proxy statement but a full Form 8-K report on management changes.
2020-08-03 English
Regulatory Filings 2020
Regulatory Filings
2020-08-03 English
424B3
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed by AdaptHealth Corp. It includes detailed information about the appointment of a new board member, David S. Williams III, to the company's board of directors. The text describes the board expansion, the appointment process, and biographical details of the new director. There is no financial data or earnings information, nor is it a report of voting results or a proxy statement. The primary content is about changes in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length and detail support this classification with high confidence.
2020-07-30 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC by AdaptHealth Corp. The key content is about the appointment of a new director to the board, including details about the board size increase, the new director's term, independence status, and indemnification agreement. There is no financial data or report content, but rather an announcement of changes in the company's board of directors. This matches the definition of Board/Management Information (MANG). The document length is about 5948 characters, which is sufficient to contain substantive information about the board changes. Therefore, the classification is MANG with high confidence.
2020-07-30 English
Regulatory Filings 2020
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC referencing a Registration Statement on Form S-1 filed by AdaptHealth Corp. It requests acceleration of the effectiveness of the Registration Statement under Rule 461 of the Securities Act of 1933. The document is short (1498 characters) and is a correspondence related to a regulatory filing, not the filing itself. It does not contain financial data or report content but is a procedural communication regarding the registration statement. Therefore, it fits best under Regulatory Filings (RNS).
2020-07-29 English
FORM 424B3
Capital/Financing Update Classification · 95% confidence The document is a Form 424B3 prospectus filed pursuant to Rule 424(b)(3) under the Securities Act, related to a secondary offering of shares by a selling securityholder. It includes detailed information about the securities being offered, risk factors, use of proceeds, market information, management discussion, business description, executive compensation, and other related disclosures typical of a prospectus for a securities offering. The document is not an annual report, earnings release, or any other financial report but rather a capital markets filing related to a financing transaction. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full prospectus text, not just an announcement or a brief notice, supporting a high confidence classification.
2020-07-29 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.